A40 EFL Registry: A Multicenter Prospective Study to Determine the Role of EFL in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Home Mechanical Ventilation Protocol ID: SRC_HRC_VectorEURegistry_2019_10820
- Conditions
- COPDemphysema10006436
- Registration Number
- NL-OMON56616
- Lead Sponsor
- Philips
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
COPD (FEV1 <60% predicted and FEV1/VC < 0.7)
Age > 40 years
Chronic hypercapnia (daytime PaCO2 > 6.0 kPa)
No Clinical diagnosis of OSA
Smoking history > 10 pack year
BMI <= 35kg/m2
Hypercapnic respiratory acidosis defined as pH <7.35
Acute coronary syndrome and unstable angina
Cognitive impairment that would prevent informed consent into the trial and/or
inability to comply with the protocol
Patients undergoing renal replacement therapy
Patients with serious comorbidities confirming prognosis likely to be less than
12-months
Pregnant
CHF with EF less than 45% determined by Echo if available
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Overall Prevalence of EFL in Ventilated hypercapnic COPD patients, as defined<br /><br>as the percentage participants exhibiting a DeltaXrs value greater than or<br /><br>equal to 2.8 at study initiation and at 6 months post therapy.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Descriptive outcomes with respect to:<br /><br>- the range of EPAP necessary to overcome EFL<br /><br>- longitudinal change of EFL with time and preceding an COPD exacerbation<br /><br>- the phenotypic characteristics of COPD most associated with nocturnal EFL<br /><br>- Effect of EFL-titrated NIV on quality of life, dyspnea, arterial blood gases,<br /><br>exercise tolerance, patient comfort, lung function, ventilatory efficacy and<br /><br>patient-ventilator asynchrony, patient effort, and lung inflation. </p><br>